The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFOX versus POF (paclitaxel plus FOLFOX) versus IP PAC (intraperitoneal paclitaxel plus FOLFOX) as a first-line treatment in advanced gastric cancer (AGC): A multicenter, randomized phase II trial, FNF-004 trial.
 
Rongbo Lin
No Relationships to Disclose
 
Hui Li
No Relationships to Disclose
 
Yigui Chen
No Relationships to Disclose
 
Jinfeng Zhu
No Relationships to Disclose
 
Peicheng Lin
No Relationships to Disclose
 
Wujin Chen
No Relationships to Disclose
 
Wenzheng Fang
No Relationships to Disclose
 
Jie Liu
No Relationships to Disclose
 
Shen Zhao
No Relationships to Disclose
 
Nanfeng Fan
No Relationships to Disclose